Promosome, a biotechnology company based in New York, has completed a Series B round of funding worth $9.6 million, from an undisclosed group of investors. The round was oversubscribed by $2.1 million.
Press release:
Promosome LLC, a biotechnology company specializing in innovative technologies related to the regulation of protein synthesis, today announced the successful completion of its Series B Funding Round.
